Table 2 Baseline characteristics of intervention and reference group subjects: descriptive statistics and group comparisons. Values are means ±SD (95 % confidence interval for means)
Intervention Group (N = 27) | Control Group (N = 26) | p-value | |
|---|---|---|---|
Age (year) | 78.2 ± 5.6 | 81.4 ± 4.3 | 0.05 |
% Female | 62 % | 79 % | 0.25 |
Number drugs/day | 3.3 ± 1.7 | 4.2 ± 2.4 | 0.18 |
Height (cm) | 161.5 ± 10.9 | 154.9 ± 6.9 | 0.03 |
Weight (Kg) | 70.9 ± 14.9 | 65.5 ± 12.9 | 0.23 |
BMI (Kg /m2) | 27.1 ± 4.4 | 27.8 ± 5.1 | 0.64 |
Mini-Mental State Examination | 29.1 ± 1.4 | 28.7 ± 1.4 | 0.49 |
Fall efficacy scale | 20.5 ± 4.3 | 22.8 ± 10.3 | 0.36 |
POMA score | 14.8 ± 1.3 | 14.7 ± 1.4 | 0.87 |
Late life function | |||
- Overall Function | 66.8 ± 9.6 | 66.5 ± 6.7 | 0.90 |
- Upper Extremity Function | 82.9 ± 11.7 | 79.2 ± 8.0 | 0.26 |
- Basic Lower Extremity Function | 82.4 ± 12.4 | 81.3 ± 13.6 | 0.79 |
- Advanced Lower Extremity Function | 59.6 ± 12.4 | 61.2 ± 10.4 | 0.66 |